Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manoj Chelvanambi

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Nature Medicine|April 20, 2022
Targeting the gut and tumor microbiota in cancerElizabeth M Park, Manoj Chelvanambi, Neal Bhutiani, et al.
Cancer Immunology, Immunotherapy : CII|May 30, 2019
Impact of combination immunochemotherapies on progression of 4NQO-induced murine oral squamous cell carcinomaSonja Ludwig, Chang-Sook Hong, Beatrice M Razzo, et al.
Cancer|March 15, 2026
High dietary fiber is associated with improved outcomes in patients with melanoma and sarcoma treated with immunotherapy regardless of gut microbiome dysbiosis and social vulnerabilityBrittany C Fields, Raymond S Traweek, Kai Jiang, et al.
Journal of Medicinal Chemistry|August 20, 2021
Mechanistic Investigation of Site-specific DNA Methylating Agents Targeting Breast Cancer CellsLeah L Lowder, Matthew Powell, Sean E Miller, et al.
Journal for Immunotherapy of Cancer|November 16, 2021
Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint-refractory advanced melanomaWalter J Storkus, Deena Maurer, Yan Lin, et al.
JCO Precision Oncology|July 10, 2025
Cancer Testis Antigen Expression Correlates With Immune Activation and Survival in Small Bowel Neuroendocrine TumorsReed I Ayabe, Y David Seo, Brenda Melendez, et al.
JAMA Dermatology|August 30, 2023
Gut Microbiome in Patients With Early-Stage and Late-Stage MelanomaRussell G Witt, Samuel H Cass, Tiffaney Tran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2023
Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch SyndromeNan Deng, Laura Reyes-Uribe, Johannes F Fahrmann, et al.
Nature Medicine|September 22, 2022
Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiomeRebecca C Simpson, Erin R Shanahan, Marcel Batten, et al.
Nature|July 19, 2023
Diverse clonal fates emerge upon drug treatment of homogeneous cancer cellsYogesh Goyal, Gianna T Busch, Maalavika Pillai, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Nature Medicine|April 20, 2022
Targeting the gut and tumor microbiota in cancerElizabeth M Park, Manoj Chelvanambi, Neal Bhutiani, et al.
Cancer Immunology, Immunotherapy : CII|May 30, 2019
Impact of combination immunochemotherapies on progression of 4NQO-induced murine oral squamous cell carcinomaSonja Ludwig, Chang-Sook Hong, Beatrice M Razzo, et al.
Cancer|March 15, 2026
High dietary fiber is associated with improved outcomes in patients with melanoma and sarcoma treated with immunotherapy regardless of gut microbiome dysbiosis and social vulnerabilityBrittany C Fields, Raymond S Traweek, Kai Jiang, et al.
Journal of Medicinal Chemistry|August 20, 2021
Mechanistic Investigation of Site-specific DNA Methylating Agents Targeting Breast Cancer CellsLeah L Lowder, Matthew Powell, Sean E Miller, et al.
Journal for Immunotherapy of Cancer|November 16, 2021
Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint-refractory advanced melanomaWalter J Storkus, Deena Maurer, Yan Lin, et al.
JCO Precision Oncology|July 10, 2025
Cancer Testis Antigen Expression Correlates With Immune Activation and Survival in Small Bowel Neuroendocrine TumorsReed I Ayabe, Y David Seo, Brenda Melendez, et al.
JAMA Dermatology|August 30, 2023
Gut Microbiome in Patients With Early-Stage and Late-Stage MelanomaRussell G Witt, Samuel H Cass, Tiffaney Tran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2023
Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch SyndromeNan Deng, Laura Reyes-Uribe, Johannes F Fahrmann, et al.
Nature Medicine|September 22, 2022
Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiomeRebecca C Simpson, Erin R Shanahan, Marcel Batten, et al.
Nature|July 19, 2023
Diverse clonal fates emerge upon drug treatment of homogeneous cancer cellsYogesh Goyal, Gianna T Busch, Maalavika Pillai, et al.
Pageof 3